⌘K

Home/Filings/4/0001209191-22-038989

4//SEC Filing

Dagnon Terry 4

Accession 0001209191-22-038989

CIK 0001649989other

View on SEC.gov Company Profile

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 5:08 PM ET

Size

4.7 KB

Accession

0001209191-22-038989

Insider Transaction Report

Form 4

Period: 2022-06-21

Outlook Therapeutics, Inc.OTLK

Chief Operating Officer

Transactions

Purchase
Common Stock
2022-06-21$1.05/sh+10,000$10,500→ 1,173,058 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Outlook Therapeutics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1

filerCIK 0001760510

Filing Metadata

Form type: 4
Filed: Jun 22, 8:00 PM ET
Accepted: Jun 23, 5:08 PM ET
Size: 4.7 KB

View on SEC.gov